Cyntegrity Expands Operations into the USA
Cyntegrity, today announced its expansion into the USA with the appointment of David Lacagnina to its senior management team.
Dec
2019
Oct
2019
Release Notes | MyRBQM® Portal Version 6.0.6
MyRBQM Portal V6.0.6 has released! We're constantly working to improve your Risk-Based Quality Management experience, here's a summary of what has changed.
Aug
2019
Pharma Supply Chain Consortium Selects Cyntegrity for the Innovative MYTIGATE Initiative
A German pharma supply chain consortium formed by esteemed industry leaders Bayer, Boehringer Ingelheim, Frankfurt University of Applied Sciences, GEFCO, and others, announces its partnership with risk-based quality management pioneer Cyntegrity Germany GmbH.
Jul
2019
No Need for Data Detectives with RBQM
Spare yourself a fall-from-grace by so called 'data detectives'. Implement RBQM, better sooner than later, and detect problems prior to publication.
Jul
2019
Practice-Oriented Research Project “Pharma Supply Chain Risk Management in Air Freight” Started
Cyntegrity project partner in digitization of pharmaceutical logistics: Frankfurt UAS' research project ensures greater transparency and security in the pharmaceutical supply chain.
Jun
2019
A Big Thank You to All Our Poster Visitors at DIA 2019!
¡Buenos DIAs! Blown away that so many folks visited our QTLs vs KRIs poster presentation! Here is the infographic in the event that you plan to do home-work.
Jun
2019
Cyntegrity Launches MyRBQM® Portal
MyRBQM Portal is world's first one-stop clinical trial optimization solution and opens the door to fully fledged risk-based quality management. Get your free user license today!
Apr
2019
FDA Q&A Draft Guidance Document: The RBM Process-Technology Fit
Our expert team reviewed the March 2019 RBM Q&A draft guidance document and extended the FDA guidance with RBM solution specific insights and a MindMap to help you even further.
Mar
2019
Your Practical Guide to Understanding Clinical KRIs
Our key risk indicator infographic will give you a foundational understanding of KRIs, provide valuable examples of KRIs, and guide you towards getting started with your risk-based monitoring (RBM) program.
Feb
2019
3 Critical Aspects of Clinical Trial Conduct that Affect the Totality of Evidence
Even without it being mandated, health authorities typically expect pharma and biotech companies to conduct two well-controlled Phase 3 trials demonstrating efficacy and safety. Still today this principle ensues discussions regarding the quantity and quality of the evidence needed to establish effectiveness.